{"id":54461,"date":"2023-03-03T12:05:48","date_gmt":"2023-03-03T11:05:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/u-s-home-infusion-therapy-market-report-2022-increasing-innovations-in-home-infusion-therapies-bolsters-growth-researchandmarkets-com\/"},"modified":"2023-03-03T12:05:48","modified_gmt":"2023-03-03T11:05:48","slug":"u-s-home-infusion-therapy-market-report-2022-increasing-innovations-in-home-infusion-therapies-bolsters-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/u-s-home-infusion-therapy-market-report-2022-increasing-innovations-in-home-infusion-therapies-bolsters-growth-researchandmarkets-com\/","title":{"rendered":"U.S. Home Infusion Therapy Market Report 2022: Increasing Innovations in Home Infusion Therapies Bolsters Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2022 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030. The market is anticipated to expand at a CAGR of 7.5% from 2022 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn’s disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market’s growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.\n<\/p>\n

\nGrowing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.\n<\/p>\n

\nIncreasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.\n<\/p>\n

\nIncreasing patients’ preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities\n<\/p>\n

\nU.S. Home Infusion Therapy Market Report Highlights<\/strong>\n<\/p>\n